Edward Murphy biography
Edward L. Murphy serves as Independent Director of the Company. Mr. Murphy currently serves as a senior vice president and a partner of Dover Investments Ltd., a private investment firm. Throughout his career, Mr. Murphy’s duties have included investment analysis of various types of investment projects in real estate and financial services. Currently, Mr. Murphy serves on the board of directors of several Canadian publicly reporting companies that have interests in various industries. He has been a Director at Empire Minerals Corporation Inc. since January 2016, at Digicrypts Blockchain Solutions Inc. since June 2011, at Lakefield Marketing Corporation since February 2018, and at the Mosport Park Entertainment Corporation since April 30, 1997. He served as a Director at Aurquest Resources from May 2003 to December 2017. Mr. Murphy’s experience in the capital markets outside the United States and his involvement in investment analysis shall be a benefit to the Board of Directors.
What is the salary of Edward Murphy?
As the Independent Director of Co-Diagnostics Inc, the total compensation of Edward Murphy at Co-Diagnostics Inc is $29,750. There are 7 executives at Co-Diagnostics Inc getting paid more, with Dwight H. Egan having the highest compensation of $676,875.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Edward Murphy?
Edward Murphy is 60, he's been the Independent Director of Co-Diagnostics Inc since 2019. There are 5 older and 4 younger executives at Co-Diagnostics Inc. The oldest executive at Co-Diagnostics Inc is Richard Serbin, 75, who is the Independent Director.
What's Edward Murphy's mailing address?
Edward's mailing address filed with the SEC is 2401 S. FOOTHILL DRIVE SUITE D, , SALT LAKE CITY, UT, 84109.
Insiders trading at Co-Diagnostics Inc
Over the last 7 years, insiders at Co-Diagnostics Inc have traded over $2,459,090 worth of Co-Diagnostics Inc stock and bought 8,205 units worth $11,819,010 . The most active insiders traders include Reed L Benson, James B Nelson, eDwight H Egan. On average, Co-Diagnostics Inc executives and independent directors trade stock every 79 days with the average trade being worth of $38,652. The most recent stock trade was executed by Brian Lee Brown on 20 March 2023, trading 3,000 units of CODX stock currently worth $5,700.
What does Co-Diagnostics Inc do?
co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are
What does Co-Diagnostics Inc's logo look like?
Co-Diagnostics Inc executives and stock owners
Co-Diagnostics Inc executives and other stock owners filed with the SEC include:
-
Dwight H. Egan,
Chairman, CEO & Pres -
Dwight Egan,
Chairman of the Board, President, Chief Executive Officer -
Reed Benson,
Chief Financial Officer, Secretary -
Brent Satterfield,
Chief Technology Officer -
Richard Serbin,
Independent Director -
James Nelson,
Independent Director -
Eugene Durenard,
Independent Director -
Edward Murphy,
Independent Director -
Dr. Brent C. Satterfield Ph.D.,
Co-Founder & Member of Scientific Advisory Board -
Cameron Gundry,
Head of Commercialization LATAM/EUR -
Dr. Mayuranki Almaula,
Sr. VP of Overseas Operations & Strategic Alliances -
Andrew Benson,
Head of Investor Relations -
Dr. Jesse Montgomery,
Chief Scientific Officer -
Brian L. Brown CPA,
CFO & Company Sec. -
Brian Lee Brown,
Chief Financial Officer -
Llc Reagents,,
-
2030 Capital, Llc America,
10% owner -
Ted Murphy,
-
Richard David Abbott,
President